Postrigo NeuroLF PET System Nabs FDA Clearance
Positrigo, a Swiss company, received FDA clearance for its NeuroLF brain PET system, designed to diagnose and monitor brain disorders.
Positrigo, a Swiss company, received FDA clearance for its NeuroLF brain PET system, designed to diagnose and monitor brain disorders.
According to a February 2015 market research report from Bio-Tech Systems Inc, advances in neurological and cardiac imaging are predicted to fuel United States growth for SPECT and PET radiopharmaceutical markets in the second half of the decade.
Positrigo, a Swiss company, received FDA clearance for its NeuroLF brain PET system, designed to diagnose and monitor brain disorders.